The Impact of Multimedia Childbirth Prediction on Parturients and Their Spouses (multimedia)

Department of Nurse-Midwifery and Women Health Graduate Institute of Nurse Midwifery

Multimedia birth prediction intervention helps mothers and their spouses reduce the number of trips to the hospital, reduce anxiety, and increase self-confidence. A total of 83 couples were accepted for cases, with a 10% attrition rate. so, A total of 95 couples were admitted and divided into the experimental group and the intervention measures were implemented Experimental group. Fill out basic demographic and obstetric variables, self-confidence visual analog scale, situational-trait anxiety scale-situational anxiety part at 37 weeks of pregnancy, at the first visit to the hospital, and one hour after admission to the hospital for delivery

Study Overview

• Status: Recruiting
• Conditions: Multimedia
• Intervention / Treatment: Behavioral: multimedia; Behavioral: Usual Care

Detailed Description

More than 90% of pregnant women are prone to anxiety and fear due to unexpected and uncontrollable birth signs before delivery and because they cannot control their own condition.

Pregnant women who receive prenatal education can reduce their fear, depression, anxiety and stress about childbirth, increase their self-confidence during childbirth, and thus gain a positive childbirth experience. As a quasi-experimental study, cases were accepted using a random method. The number of cases admitted was 83 couples, with a 10% attrition rate. Therefore, a total of 95 couples were admitted and divided into an experimental group and a control group. The experimental group received intervention measures, and the control group received intervention measures.

At 37 weeks of pregnancy, at the first visit to the hospital for examination, and one hour after admission, basic demographic and obstetric variables, self-confidence visual analogy scale, and situational-trait anxiety scale-situational anxiety were filled in, and statistical analysis was performed. The methods were descriptive statistics, independent t test, chi-square test, analysis of variance, generalized estimating equations, and linear regression between the experimental and control groups.

• Study Type: Interventional
• Enrollment (Estimated): 190
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: CHIA CHUN CHUNG; Phone Number: 886-978800237kelly680922@gmail; Email: kelly680922@gmail.com

Study Locations

• Taiwan
  • Hsinchu, Taiwan, 300
    • Recruiting
    • MacKay Memorial Hospital
    • Contact: CHUNG CHIA-CHUN, master; Phone Number: 0978-800237; Email: kelly680922@gmail.com.tw

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

1. Low-risk first-time mothers over 20 years old and their spouses
2. Pregnancy >37 weeks, pregnancy <40 weeks
3. Single birth, head position
4. Vaginal producers
5. Those who can listen, speak, read and write Chinese

4. Diagnosed by a doctor as prenatal mental illness 5. The fetus' condition requires admission to a moderate or severe ward or intensive care unit.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Placebo Comparator: usual care	Behavioral: Usual Care; When mothers and their spouses reported to the health classroom on the 37-week prenatal check-up day, The control group will be given general care guidance,
Experimental: Multimedia; When mothers and their spouses reported to the health classroom on the 37-week prenatal check-up day, while the experimental group will receive general care and multimedia birth control education intervention	Behavioral: multimedia; When mothers and their spouses reported to the health classroom on the 37-week prenatal check-up day, the researcher explained the motivation and process of the research. After the women and their spouses agreed to join the study, they were randomly assigned to the experimental group and the control group. The control group will be given general care guidance, while the experimental group will receive general care and multimedia birth control education intervention, and the mothers and their spouses will download and watch the video through Line, an instant messaging software on their mobile phones.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Self-Confidence Visual Analog Scale	0 points represent the lowest self-confidence and 10 points represent the highest self-confidence	Time range: 37 weeks of pregnancy, first visit to the hospital for examination, one hour of hospitalization
Situational-Trait Anxiety Inventory-Situational Anxiety Section	The range is from "1" for almost never to "4" for almost always, with higher total scores indicating a higher level of anxiety in the individual.	Time range: 37 weeks of pregnancy, first visit to the hospital for examination, one hour of hospitalization

Collaborators and Investigators

• Sponsor: Mackay Memorial Hospital

Study record dates

Study Major Dates

• Study Start (Actual): February 3, 2024
• Primary Completion (Estimated): August 31, 2025
• Study Completion (Estimated): August 31, 2025

Study Registration Dates

• First Submitted: December 25, 2024
• First Submitted That Met QC Criteria: February 3, 2025
• First Posted (Actual): February 10, 2025

Study Record Updates

• Last Update Posted (Estimated): August 15, 2025
• Last Update Submitted That Met QC Criteria: August 11, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Keywords: birth signs, anxiety, self-confidence, number of home visits
• Other Study ID Numbers: 24MMHIS256e

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No